This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Astellas Pharma Gmbh. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2022
Title: Hirotsugu Tanaka: Innovator in Antibody Therapeutics
Introduction
Hirotsugu Tanaka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antibody therapeutics, holding a total of four patents. His work focuses on developing innovative solutions for treating various medical conditions.
Latest Patents
Tanaka's latest patents include an anti-human NGF antibody Fab fragment and methods for treating postoperative pain related to NGF. This invention aims to provide a superior anti-human NGF antibody Fab fragment that maintains high neutralizing activity while reducing systemic side effects. It expresses a local drug effect, offering a promising approach to postoperative pain management. Another notable patent is the anti-human PAI-1 antibody, which is designed to prevent or treat pulmonary fibrosis by binding to active human PAI-1 and inhibiting its effects.
Career Highlights
Hirotsugu Tanaka is currently associated with Astellas Pharma GmbH, where he continues to advance his research in antibody development. His innovative work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of therapeutic antibodies.
Collaborations
Tanaka collaborates with esteemed colleagues, including Masazumi Kamohara and Yukari Koya, to further enhance the impact of his research and inventions.
Conclusion
Hirotsugu Tanaka's contributions to antibody therapeutics exemplify the importance of innovation in medicine. His patents reflect a commitment to improving patient outcomes through advanced therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile